214 related articles for article (PubMed ID: 27408611)
1. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
[TBL] [Abstract][Full Text] [Related]
3. Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD.
Jiamsakul A; Kerr SJ; Ng OT; Lee MP; Chaiwarith R; Yunihastuti E; Van Nguyen K; Pham TT; Kiertiburanakul S; Ditangco R; Saphonn V; Sim BL; Merati TP; Wong W; Kantipong P; Zhang F; Choi JY; Pujari S; Kamarulzaman A; Oka S; Mustafa M; Ratanasuwan W; Petersen B; Law M; Kumarasamy N;
Trop Med Int Health; 2016 May; 21(5):662-74. PubMed ID: 26950901
[TBL] [Abstract][Full Text] [Related]
4. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
[TBL] [Abstract][Full Text] [Related]
5. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
6. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
[TBL] [Abstract][Full Text] [Related]
7. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
[TBL] [Abstract][Full Text] [Related]
8. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
[TBL] [Abstract][Full Text] [Related]
9. Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia region, Ethiopia: a retrospective cohort study.
Tesfamariam K; Baraki N; Kedir H
BMC Res Notes; 2016 Dec; 9(1):512. PubMed ID: 27998310
[TBL] [Abstract][Full Text] [Related]
10. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
Gesesew HA; Ward P; Woldemichael K; Mwanri L
PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
[TBL] [Abstract][Full Text] [Related]
11. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V
HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312
[TBL] [Abstract][Full Text] [Related]
12. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
[TBL] [Abstract][Full Text] [Related]
13. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
[TBL] [Abstract][Full Text] [Related]
14. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.
Haile D; Takele A; Gashaw K; Demelash H; Nigatu D
PLoS One; 2016; 11(10):e0164299. PubMed ID: 27716827
[TBL] [Abstract][Full Text] [Related]
16. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
McGrath N; Lessells RJ; Newell ML
HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
[TBL] [Abstract][Full Text] [Related]
17. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
[TBL] [Abstract][Full Text] [Related]
18. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
Tweve EN; Kayabu D; Nassari NO; Todd J
Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
[TBL] [Abstract][Full Text] [Related]
19. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
[TBL] [Abstract][Full Text] [Related]
20. Improved survival in HIV treatment programmes in Asia.
De La Mata NL; Kumarasamy N; Khol V; Ng OT; Van Nguyen K; Merati TP; Pham TT; Lee MP; Durier N; Law M
Antivir Ther; 2016; 21(6):517-527. PubMed ID: 26961354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
